Iranian Scientists at Avicenna Research Institute Develop Cell Therapy for Infertility Treatment
“The main goal of the Institute is to apply life science research using modern technologies; specially in three key areas of treatment of human infertility to rejuvenate the population, laboratory production of heavy livestock embryos to improve food security, and production of biological products such as poultry, livestock, and aquatic vaccines,” said Ramin Qahremanzadeh, the vice-president for Research and Technology at Avicenna Research Institute.
“As a leading center in Iran, Avicenna Research Institute has succeeded in developing cell therapy methods for the treatment of infertility, specially in cases of premature ovarian failure and reduced ovarian reserve,” he added.
"We have conducted extensive studies at the Institute on menstrual blood stem cells, which are a unique, accessible, and painless source for sampling. These cells enjoy the ability to transform into a variety of body tissues. After successfully conducting safety and efficacy studies in animal models, all human phases of this research have been completed, and we are currently in the process of obtaining final permits for clinical use in medical centers."
Also, in September, Iranian scientists at the Royan Research Institute’s Cord Blood Bank had started treatment of patients with severe arthritis with umbilical cord stem cells, describing the initial results as highly successful.
“We have started treating patients with severe arthritis, including knee, hip and shoulder joint arthritis, with umbilical cord stem cells since last week, and the initial research results have been very promising,” said Morteza Zarrabi, the managing director of the Royan Research Institute’s Cord Blood Bank.
Noting that the product has reached a stage where umbilical cord stem cells can now be used to treat patients with arthritis, he said, “We are making efforts to provide the possibility of treating various diseases by utilizing stem cells from blood and umbilical cord tissue, and the initial results have been very successful.”
4155/v
